Guillermo Marmol
Chief Executive Officer at Porosome Therapeutics.
Earliest Form D on file: Mar 2026
Filed Mar 24, 2026Amendment
Porosome Therapeutics
Therapies that restore the cell's secretory machinery
Biotech, Boston MA
Signed as Chief Executive Officer